Industry
Gallium-68 core technology secured to localise drug for intractable cancer diagnosis
South Korea’s Ministry of Science and ICT and the Korea Atomic Energy Research Institute said on Feb. 13 they had secured all key component technologies for a gallium-68 generator, laying the groundwork to localise radiopharmaceuticals used to diagnose intractable cancers. The team developed an adsorption material that selectively elutes gallium-68 and reported about 70 percent elution efficiency. It can produce radiopharmaceuticals for six patients per elution and is usable for a year.
